Our data, however, show that EOMES is required for efficient CD8+ T-cell expansion, which is in line with a previously described role of EOMES in enhancing CD8+ T-cell proliferation and survival and thereby, improving tumor control in a mouse model of cancer immunotherapy [42]. The gene discussed is CD8A; the disease is neoplasm.